Showing results (1071-1080 of 1,761) with videos related to
Sort By:
Pageof 177
Journal of Parkinson'S Disease|May 23, 2022
Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's DiseaseKuan-Yin Tseng, Tung-Tai Kuo, Vicki Wang, et al.Journal of Parkinson'S Disease|May 23, 2022
Heterogeneity of PD-MCI in Candidates to Subthalamic Deep Brain Stimulation: Associated Cortical and Subcortical ModificationsQuentin Devignes, Sami Daoudi, Romain Viard, et al.Journal of Parkinson'S Disease|June 7, 2021
Data Protection Using Polymorphic Pseudonymisation in a Large-Scale Parkinson's Disease StudyBernard E van Gastel, Bart Jacobs, Jean PopmaJournal of Parkinson'S Disease|June 7, 2021
The Human Hippocampus in Parkinson's Disease: An Integrative Stereological and Proteomic StudySandra Villar-Conde, Veronica Astillero-Lopez, Melania Gonzalez-Rodriguez, et al.Journal of Parkinson'S Disease|June 7, 2021
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson's Disease: A Randomized, Placebo-Controlled, Phase 1 StudyWerner Poewe, Dieter Volc, Klaus Seppi, et al.Journal of Parkinson'S Disease|June 7, 2021
Bringing Advanced Therapies for Parkinson's Disease to the Clinic: An Analysis of Ethical IssuesKristina HugJournal of Parkinson'S Disease|June 7, 2021
Gene Therapy to Modulate Alpha-Synuclein in SynucleinopathiesIvette M Sandoval, David J Marmion, Kimberly T Meyers, et al.Journal of Parkinson'S Disease|May 31, 2021
Short Pulse and Conventional Deep Brain Stimulation Equally Improve the Parkinsonian Gait DisorderAline Seger, Alessandro Gulberti, Eik Vettorazzi, et al.Journal of Parkinson'S Disease|May 31, 2021
Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor CortexSydney Weber Boutros, Jacob Raber, Vivek K UnniJournal of Parkinson'S Disease|February 3, 2020
An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson's Disease and G2019S LRRK2 CohortsShalini Padmanabhan, Thomas A Lanz, Donal Gorman, et al.Pageof 177